Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Recruiting now · Phase 4
Conditions studied: Asthma
In brief
This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.
Key facts
- Study ID
- NCT07228052
- Run by
- Montefiore Medical Center
- People needed
- 182
- Starts
- 2026-07-23
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-07-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults ≥18 years old presenting to the ED with an asthma exacerbation
- Diagnosed with asthma per International Classification of Diseases, 10th Revision (ICD-10) criteria or by the treating clinician
- Discharged from the ED with a primary diagnosis of asthma exacerbation
- Initiated systemic corticosteroids during the ED visit
- Must be English or Spanish speaking
You may not qualify if…
- Current use of systemic corticosteroids, including Emergency Medical Services (EMS) administration before ED arrival
- History of severe adverse reactions to corticosteroids
- Heart failure and uncontrolled diabetes (glucose >300mg/dL in the ED)
- Pregnancy or breastfeeding as prednisone is the preferred treatment for asthma in this population
- Inability to provide informed consent
Where it is running
- Montefiore Medical Center — The Bronx, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.